- Published date :
-
May 19, 2009
- Expired date :
-
May 19, 2040
May 19, 2009 – Wilmington, DE – Today AstraZeneca (NYSE: AZN) released the following statement in response to the confirmation of Dr. Peggy Hamburg as Commissioner of the Food and Drug Administration (FDA):
“AstraZeneca is pleased by the timely confirmation of Dr. Hamburg as FDA Commissioner. Her leadership is vitally important as the agency strives to safeguard people’s health and match the swift pace of medical innovation in America.
“Our industry relies on an efficient and well-resourced regulator to help us deliver safe, effective medicines that can improve patient health.
”As a founding member of the Alliance for a Stronger FDA, AstraZeneca will continue to advocate for increased Congressional funding so the agency can have the technology and people it needs to help bring medicines from the laboratory to the patient in a consistent, systematic way.”
About AstraZeneca
AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.
For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com.
Media Contact:
- Tony Jewell, AstraZeneca: 302-885-4594
